Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2026
A singular base-editing platform for polyfunctional multiplex engineering of immune cellsJoseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|October 1, 1994
A program to measure new energetic particle nuclear interaction cross sectionsT G Guzik, S Albergo, C X Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2015
Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL NucleasesMark J Osborn, Beau R Webber, Friederike Knipping, et al.
The Science of the Total Environment|February 4, 2018
Spatial variation of mercury bioaccumulation in bats of Canada linked to atmospheric mercury depositionJohn Chételat, M Brian C Hickey, Alexandre J Poulain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2024
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapiesJoseph G Skeate, Emily J Pomeroy, Nicholas J Slipek, et al.
Elife|May 16, 2020
Efficient targeted integration directed by short homology in zebrafish and mammalian cellsWesley A Wierson, Jordan M Welker, Maira P Almeida, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.
Pageof 18